• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Healthcare·JLHL.BO
Share

Jupiter Life Line Hospitals Limited Stocks

₹ 246.35Last Updated 21.10.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

₹ 852.83M

₹ 246.35
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Jupiter Life Line Hospitals Limited, established in Mumbai, India, in 2002, operates as a multi-specialty healthcare provider throughout the country under its Jupiter brand. The company delivers a comprehensive range of medical and surgical services spanning numerous disciplines. These include diverse surgical fields such as bariatric, cardiac, general, minimal access, HPB, surgical gastroenterology, neurosurgery, organ transplant, orthopedics (including robotic knee replacement), and plastic and cosmetic surgery. Additionally, Jupiter Life Line Hospitals offers specialized care in cardiology, chest medicine, dental care, dermatology, ENT, endocrinology and diabetes, gastroenterology, hematology and bone marrow transplantation, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, nutrition and dietetics, obstetrics and gynecology, oncology, ophthalmology, pediatrics, pain management, rehabilitation, and rheumatology. Beyond its healthcare operations, the company also manages the Fortune Park Lake City Hotel located in Thane.

Company Valuation

Slightly overvalued
3/7

From both historical and forecast perspectives, the stock is slightly overpriced compared to similar stocks. Specifically, the stock is 'expensive' on P/E, neutral on EV/

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

22.10.2026 14:02

eBay shares rose following the announcement of a 9% workforce reduction. Should you buy these stocks?

22.10.2026 13:20

The Euro vs. the Barricades: What Affects Its Exchange Rate More Than the Crisis in France

22.10.2026 13:06

Another sell-off in tech stocks: Meta and Tesla failed to calm the market

22.10.2026 12:23

Nebius highlighted the difference from CoreWeave amid concerns about Neocloud's debt

22.10.2026 11:49

Meta is ramping up its investment in AI: increasing spending and preparing to issue a new class of shares

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026